Tumor growth after CD133 negative B16-F10 cell implantation was probably resulted by ability of this cell population to get stem cell properties by accumulation of genetic changes or by environmental factors and signals coming from the niche of the recipient's organism [38, 39]. The gene discussed is PROM1; the disease is neoplasm.